News

Ulimorelin, if approved, is expected to be a first-in-class drug for the treatment of gastrointestinal (GI) dysmotility indications in acute care settings. Ulimorelin is a small molecule, intravenously-administered

The compnay claims that Maris Plus stent features an exclusive cell design at the stent ends. This allows physicians to place several stents in series without stiffening the

The trial, which is being conducted by the Hoosier Oncology Group, is open for enrollment at the Baylor Sammons Cancer Centre, Dallas, Texas; Indiana University Melvin and Bren

Enzon’s specialty pharmaceutical business includes four marketed products, Oncaspar, Adagen, DepoCyt, and Abelcet, as well as a manufacturing facility in Indianapolis, Indiana. As previously announced, Enzon entered into

With the completion of the design of the self-metering cartridge, a limited production run will be released, which will enable the company to adapt its first cardiovascular test,

The NDA submission follows a pre-NDA meeting with the FDA and the recently announced results from the phase 3 trial of Axiron. The trial demonstrated that after four

Eddie Catalfamo, president and CEO of Santica Research Labs, said: “This unique supplement, made from carefully selected natural botanical extracts, targets the underlying factors that contribute to the

Cenestra said that scientific data obtained from third party academic laboratories support its proprietary formulation as having novel properties compared to other omega-3 products. These studies show that

Through the deal, American Medical Systems has a four year option to obtain distribution and license rights to Tissue Genesis’ regenerative cell technology including the Tissue Genesis Cell